October 17, 2024
Trending Now
1
Asthma Risk: Unexpected Indicator Discovered
2
Pregabalin and Topiramate Show Promise for Pediatric Migraine Prevention
3
Comparing Once-Weekly vs. Daily Insulin Administration for T2D
4
Dental Hygienist Ranks Among America’s Top Dream Jobs
5
FDA Grants Approval for Hemophilia Pen Injector
6
Study Proposes Noninvasive Predictive Biomarker for Primary Sjögren’s Syndrome
Conference Coverage
SOHO 2024
October 14, 2024
New Directions in ALL, CML, and CLL Treatment
ESMO Congress 2024
Euretina 2024
Clinical Guidelines
View MoreOctober 15, 2024
Does Teen Cannabis Use Harm Grades and School?
October 15, 2024
EULAR Develops Classification Criteria for Hand OA
October 15, 2024
New SLE Treatments Show Promise in Trials
October 14, 2024
New Targeted Therapies Recommended for Systemic Sclerosis
Commentary & Perspectives
View MoreOctober 15, 2024
Are Millions of Aging Americans Facing Dementia Alone?
October 15, 2024
New SLE Treatments Show Promise in Trials
October 15, 2024
Alien Milling, 3Shape Unveil Short Film “Molar City”
October 11, 2024
Are Extended-Stay Hotels Harming Kids’ Health?
FDA & Government News
View MoreOctober 17, 2024
FDA Nod for Novel Parkinson's Infusion Therapy
October 17, 2024
Neurodevelopmental Safety: FDA's Latest Priority
October 17, 2024
FDA Expands Sleep Disorder Drug Use to Kids 7 and Up
October 16, 2024
FDA Halts Combo Flu-COVID Shot Trial Amid Safety Risks
Business Management
View MoreOctober 01, 2024
Win the Battle for Positive Change
October 01, 2024
Viewpoint From the Editor: Another Year Almost Over – How Did We Do?
October 01, 2024